UHN has signed a licensing agreement with RaySearch Laboratories AB regarding deformable image registration technology developed at Princess Margaret Hospital. The agreement, licensed through the Technology Development and Commercialization Office at UHN, allows for the integration of UHN’s research software “Morfeus” into RaySearch’s commercial radiation treatment planning system. The aim of the relationship is to use UHN-developed tools in adaptive radiotherapy to provide better and more efficient outcomes for cancer patients around the world.
Morfeus contains a set of algorithms that make it possible to track how a dose of radiation is delivered to the patient, taking into account changes occurring in the patient’s anatomy over the course of treatment. This information is then used to further refine the treatment and reduce the risk for side effects. The techniques were developed and thoroughly validated over the last seven years by a team of scientists and physicists led by Dr. Kristy Brock.